Sarepta CEO: ‘We Have, I Believe, a Very Laudable History of Being Extraordinarily Transparent’

Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing public for a month. Financial analysts lambasted Sarepta executives for failing to disclose the fatality when the company announced a restructuring that includes stopping work on this limb-girdle program. The…

Read More

American Heart Association Backs Auxira Health to Alleviate Cardiologist Burnout

The American Heart Association’s venture arm invested in Auxira Health, a startup that embeds virtual clinical teams into cardiology practices to reduce physician burnout and expand patient access. By handling routine tasks like follow-up visits and medication refills, Auxira gives cardiologists the opportunity to focus on complex care without adding full-time staff. The post American…

Read More